Skip to main content
. Author manuscript; available in PMC: 2023 Jun 1.
Published in final edited form as: Int J Radiat Oncol Biol Phys. 2021 Nov 11;113(2):290–301. doi: 10.1016/j.ijrobp.2021.10.137

Table 2.

Radiation planning dose achieved in PTV for all patients and by cohort. ANOVA analysis between cohorts.

PTV1 PTV2 PTV3
Vprescription D99% V47.5Gy D99% Vprescription D99%
% Gy % % Gy % % Gy %
All Patients
Avg 93% 22 90% 94% 46 96% 88% 50 97%
IQR1 90% 21 84% 93% 45 95% 88% 50 97%
Median 94% 23 93% 95% 46 97% 95% 50 98%
IQR3 97% 24 96% 97% 47 99% 95% 52 99%
Cohort 1 22.5Gy 47.5Gy 50 Gy
Avg 93% 22 91% 92% 45 95% 93% 50 99%
IQR1 91% 19 83% 89% 44 93% 93% 49 99%
Median 94% 21 95% 95% 46 97% 95% 50 99%
IQR3 96% 22 96% 96% 47 98% 98% 50 100%
Cohort 2 25Gy 47.5Gy 50 Gy
Avg 93% 23 93% 95% 46 97% 96% 50 99%
Median 93% 24 94% 95% 46 98% 95% 50 100%
IQR1 90% 23 90% 94% 46 96% 95% 49 98%
IQR3 100% 25 101% 98% 47 99% 95% 50 100%
Cohort 3 25Gy 47.5Gy 52.5Gy
Avg 91% 21 84% 95% 46 97% 93% 51 98%
IQR1 87% 19 76% 93% 45 95% 95% 51 97%
Median 91% 21 83% 95% 46 97% 95% 52 98%
IQR3 97% 23 94% 97% 47 99% 95% 52 99%
Cohort 4 25Gy 47.5Gy 55 Gy
Avg 92% 23 92% 94% 46 97% 74% 51 93%
IQR1 89% 22 89% 94% 45 95% 64% 49 88%
Median 95% 23 93% 96% 46 97% 73% 51 93%
IQR3 97% 24 97% 97% 47 98% 95% 54 97%
ANOVA 0.71 <0.01 0.02 0.19 0.19 0.19 <0.01 <0.01 <0.01